Vancouver, BC, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Humanoid Global Holdings Corp. (“Humanoid Global” or the “Company”) (CSE:ROBO, FWB:0XM1, OTCPK:RBOHF) announced today changes to its management. Shahab Samimi will serve as the Chief Executive Officer of the Company effective today, and will succeed Joshua Matettore, who will assist in the leadership transition. Mr. Samimi is an experienced investor and technologist who previously assisted in the allocation of funds at 7 Gate Ventures, a VC fund with offices ...

Vancouver, BC, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Humanoid Global Holdings Corp. (“Humanoid Global” or the “Company”) (CSE:ROBO, FWB:0XM1, OTCPK:RBOHF) announced today changes to its management. Shahab Samimi will serve as the Chief Executive Officer of the Company effective today, and will succeed Joshua Matettore, who will assist in the leadership transition. Mr. Samimi is an experienced investor and technologist who previously assisted in the allocation of funds at 7 Gate Ventures, a VC fund with offices ...

Vancouver, BC, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Humanoid Global Holdings Corp. (“Humanoid Global” or the “Company”) (CSE:ROBO, FWB:0XM1, OTCQB:RBOHF), a publicly traded investment issuer focused on building and accelerating a portfolio of pioneering companies in the humanoid robotics and embodied AI sector, is pleased to announce that it has been approved to have its common shares uplisted from the OTC Pink Sheets to the OTCQB Market (“OTCQB”). The Company’s common stock began trading today on the OTCQB un ...

Core Insights - Humanoid Global Holdings Corp. has appointed Dr. Ahad Armin to its Technical Advisory Committee, enhancing its expertise in humanoid robotics and embodied AI [1][3][6] Company Overview - Humanoid Global is a publicly traded investment issuer focused on building a portfolio of pioneering companies in the humanoid robotics and embodied AI sector, providing liquidity and access to an actively managed portfolio [9] Advisory Role - Dr. Armin will advise on mechanical system design, dynamic modeling, and applied robotics to support the company's technical due diligence and portfolio development [4][6] - The advisory agreement with Dr. Armin has a term of twelve months starting from July 28, 2025, with termination rights for either party [7] Dr. Ahad Armin's Background - Dr. Armin has over a decade of experience in robotics, manufacturing, and mechanical simulation, with previous academic roles at various institutions and industry experience in intelligent automation systems and structural simulations [2][5] Stock Options and RSUs - The company has granted Dr. Armin 50,000 incentive stock options at an exercise price of $0.61, vesting quarterly over one year, and 50,000 restricted share units that will vest immediately [8]

>> WELCOME TO "BLOOMBERG ETF IQ." KATIE: THERE IS A LOT TO KEEP PUSLE OF. SCARLET: AFTER WE CARE OF THE JOBS REPORT AND EARNINGS. KATIE: THAT IS A BIG ONE.LET'S GET TO THE BIGGEST WORRIES RIGHT NOW. $17 TRILLION GLOBAL ETF INDUSTRY. WE START WITH STOCKS REBOUNDING AFTER THE SELLOFF ON FRIDAY FUELED BY WEAK JOBS DATA.SCARLET: IN A FEW MINUTES WE WILL SPEAK WITH TRAVIS SPENCE. ON THE RECORD FLOW. KATIE: WE WILL DISCUSS WHY THE FUNDS ARE HAVING A HUGE BOOST EMERGING FROM BITCOIN.ALL OF THAT AND MORE. ERIC IS W ...

Core Insights - Humanoid Global Holdings Corp. has appointed Dr. Yue Hu to its Technical Advisory Committee to enhance its technical strategy and research insights in humanoid robotics [1][2][3] - The company aims to capitalize on the projected growth of the humanoid robotics market, which Goldman Sachs estimates could reach a total addressable market of $38 billion by 2035, with expected shipments of 1.4 million units [4] - The Technical Advisory Committee will consist of leading robotics experts to support technical due diligence and advise on portfolio performance, focusing on emerging research and aligning product development with advancements in humanoid robotics [5] Company Developments - Dr. Hu will provide expertise in torque-controlled bipedal robotics and multi-modal force-feedback systems, which are critical for the future of embodied AI [3] - The advisory agreement with Dr. Hu is set for twelve months, with the option for either party to terminate at any time [6] - The company has granted Dr. Hu 50,000 incentive stock options at an exercise price of $0.61, vesting over four quarters, and 25,000 restricted share units that will vest immediately [7] Marketing and Engagement - Humanoid Global has engaged Investor Insights Systems Inc. for a four-month term to provide digital marketing services, with a total fee of $500,000 plus GST/HST [8][9] - The marketing services will include digital content creation, distribution, and market awareness campaigns to enhance the company's visibility in the humanoid robotics sector [8]

Summary of the Conference Call on China's Auto Parts Sector Industry Overview - The conference call focused on the **China Auto Parts Sector**, particularly the earnings performance of suppliers in Q225 and the evolving client mix within the industry [2][3]. Key Points and Arguments Revenue Growth Expectations - Suppliers are expected to post **encouraging revenue growth** for Q225, driven by new model launches and an increasing content value per vehicle (CPV) [2][3]. - **Fuyao** is projected to achieve **10-15% YoY revenue growth** due to overseas market share expansion and rising domestic average selling prices (ASP) [3]. - **Tuopu** and **Sanhua** are forecasted to deliver **mid-to-high single-digit YoY revenue growth**, with Tuopu expected to achieve **20%-plus QoQ revenue growth** from new orders [3]. Margin Concerns - There are significant **margin concerns** due to ongoing price competition in the auto parts sector, with most companies experiencing a decline in gross margins over the past two years [4]. - Although raw material prices have decreased, which could support margins, headwinds remain from price competition and potential cost increases from new plant ramp-ups [4][15]. Client Mix Evolution - The client mix is evolving, with **Xiaomi**, **Li Auto**, and **AITO** expected to become increasingly important for suppliers from FY24 to FY26E [2][7]. - Revenue contributions from these companies are projected to significantly increase, with some suppliers expected to derive **35-40%** of their 2026 revenue from them [7]. Upcoming Catalysts - Key catalysts for the auto parts sector in H225 include: - Delivery of orders for **Xiaomi YU7** - Launch of **Li Auto's i8** and **Tesla's Model Y L** - Strong sales from **Leapmotor** [5]. - Concerns exist that the Xiaomi YU7 could compete with the Tesla Model Y, but it is believed that the YU7 orders will largely offset any potential decline in Model Y sales [5][24]. Humanoid Robotics Supply Chain - The auto parts suppliers are making strides in the **humanoid robotics** space, leveraging their existing technology and relationships with companies like **Tesla** and **JD.com** [8][58]. - Despite a reduction in Tesla's humanoid robot sales volume guidance, there are still catalysts for growth in this area [8]. Stock Implications - The launch of new models and developments in humanoid robotics are expected to act as **share price catalysts** for supply chain companies in the short term [9]. Additional Important Insights - The analysis indicates that **Desay SV** is expected to benefit the most from the Xiaomi YU7 launch, with a projected **16.6%** revenue increase in 2026E [29]. - The report highlights the potential for **Xiaomi YU7** orders to offset revenue declines from existing customers, particularly for suppliers with higher CPV from the YU7 [24][28]. - Risks to the auto parts sector include demand dampening due to lower auto production, price pressure from automakers, and potential product recalls due to quality issues [61]. This summary encapsulates the key insights and projections discussed during the conference call, providing a comprehensive overview of the current state and future outlook of the China Auto Parts Sector.

Summary of Humanoid Sector Conference Call Industry Overview - **Industry**: Humanoid Robotics Sector in Asia Pacific, particularly focusing on China - **Key Players**: Tesla, Figure, Unitree, Agibot, UBTECH, and various component suppliers Core Insights 1. **Market Dynamics Shift**: The humanoid sector experienced a strong stock rally from January to March 2025 (+37% in China's humanoid value chain) due to ambitious targets and government support, followed by a pullback (-6%) as integrators lowered their 2025 targets and no significant breakthroughs occurred [3][18][19] 2. **Adoption and Orders**: Initial adoption and orders are expected in 2H25, with integrators targeting hundreds to thousands of units. This is crucial for sector performance as robots are anticipated to expand their task applications in industrial and commercial services [4][22] 3. **Technological Innovations**: Continuous model launches and hardware/software innovations are expected to support sector performance. Key updates from integrators like Tesla and Figure could signal progress [5][8] 4. **Government Support**: The Chinese government is playing a critical role in promoting the humanoid sector, with policies aimed at deploying 10-20k units by 2027 and providing R&D subsidies [33][34][35] Important Developments 1. **Key Events to Watch**: Upcoming events include Tesla's 2Q earnings call (July 23), World AI Conference (July 26-28), and World Robots Conference (August 8-12) [8][14] 2. **New Integrator Models**: The humanoid value chain list has been updated to include 45 stocks, reflecting the latest progress in the industry. Six new companies have been added due to their cooperation with key humanoid firms or high-potential products [9][11] 3. **Commercial Orders**: Significant commercial orders have been announced, including a Rmb91 million order from UBTECH for automotive technology tasks and a Rmb124 million contract from China Mobile for Agibot and Unitree [27][28] Potential Risks 1. **Concerns Over Delays**: Delays in adoption could hamper stock performance, as the market has already priced in various catalysts. The humanoid value chain has underperformed compared to MSCI China [18][21] 2. **Data Bottlenecks**: Companies are still seeking innovations to improve the effectiveness of humanoid robots, as data remains a bottleneck for broader task applications [21][22] Future Outlook 1. **Focus on Adoption**: The focus in 2H25 will be on downstream adoption, with expectations for broader use cases in industrial and commercial services. The ability of integrators to meet market expectations will be closely monitored [22][23] 2. **Continuous Improvements**: The sector is expected to see continuous hardware breakthroughs and software innovations, which will be critical for enhancing humanoid capabilities [41][42] Conclusion The humanoid robotics sector is at a pivotal point, with significant potential for growth driven by technological advancements and government support. However, the realization of commercial value and successful adoption will be key to sustaining market momentum.

Core Insights - Tesla Inc. reported a decline in global deliveries for the second quarter of 2025, marking a 13.5% decrease year-over-year, with total deliveries at 384,122 vehicles, the worst decline in the company's history [1][3][4] - Despite the weak delivery report, Tesla shares rose by 5%, indicating strong growth prospects [1] - The company faces increasing competition from next-generation EVs from Chinese automakers, which are gaining market share due to lower price points and frequent model updates [4] Delivery and Production Data - In Q2 2025, Tesla delivered 384,122 vehicles, including 373,728 Model 3/Y and 10,394 other models, down from the previous year [3] - Tesla produced 410,244 vehicles during the same quarter, comprising 396,835 Model 3/Y and 13,409 other models [3] Market Challenges - Tesla is experiencing challenges from rising competition, particularly from Chinese EV manufacturers, which are impacting its market share [4] - Political backlash against CEO Elon Musk is also affecting the company's reputation and sales [4] Future Growth Potential - Analysts see significant growth potential in Tesla's robotaxi service, which launched in Austin, TX, with plans for rapid expansion [5][6] - The robotaxi market is viewed as a multi-trillion-dollar opportunity, with potential to double Tesla's market capitalization by the end of 2026 [5] ETFs with Tesla Exposure - Several ETFs have substantial allocations to Tesla, including: - Simplify Volt TSLA Revolution ETF (TESL) with an AUM of $30.9 million and an expense ratio of 1.20% [2][7] - Consumer Discretionary Select Sector SPDR Fund (XLY) with an AUM of $22.7 billion, holding 16% in Tesla [2][8][9] - Vanguard Consumer Discretionary ETF (VCR) with an AUM of $6.1 billion and a 16.1% allocation to Tesla [2][10] - The Nightview Fund (NITE) with Tesla as the top holding at 14.5% of its assets and an AUM of $26.4 million [2][11] - Fidelity MSCI Consumer Discretionary Index ETF (FDIS) with an AUM of $1.8 billion and a 14.7% allocation to Tesla [2][12]

Core Insights - The humanoid robotics market is transitioning from a futuristic concept to a viable investment opportunity, with estimates suggesting it could reach a $5 trillion market by 2050 [1][2][3] Market Dynamics - The market is experiencing a turning point due to three converging trends: record labor shortages, significant reductions in AI costs (down approximately 85% since 2023), and competitive pricing for Robots-as-a-Service (RaaS) at around $30 per hour [2][3][4] - Over 450,000 warehouse roles in the U.S. remain unfilled, highlighting the labor shortage [3] Investment Vehicles - Roundhill's HUMN ETF is one of the first actively managed ETFs focused on humanoid robotics, allowing for more agile trading compared to index-based ETFs like KraneShares' KOID [4][5] - HUMN's portfolio is reviewed monthly to capitalize on emerging opportunities, contrasting with KOID's static approach [5][6] Tesla's Role - Tesla's humanoid robot, Optimus, is already operational within its factories, and the company is a significant holding in the HUMN ETF, capped at approximately 13% to mitigate risk from volatility [7][8] - Tesla's unique advantages include an in-house AI stack and large-scale manufacturing capabilities, positioning it favorably in the humanoid robotics space [8][9] Future Projections - Adoption of humanoid robotics is expected to follow a linear growth pattern through the late 2020s, with a significant inflection point in the mid-2030s as fleets scale [10] - Investors are encouraged to view HUMN as a long-term holding with potential for strong returns in shorter time frames [10] Global Exposure - HUMN ETF provides exposure to sophisticated humanoid robotics through ownership stakes in companies like Hyundai (owner of Boston Dynamics' Atlas) and Xiaomi, which are part of its portfolio [11][12] - The ETF adopts a value-chain approach, incorporating U.S. silicon producers, Chinese humanoid builders, and Japanese precision gear manufacturers to ensure comprehensive market exposure [12] Conclusion - As the humanoid robotics sector evolves, Roundhill's HUMN ETF offers a potential first-mover advantage for investors looking to capitalize on the growing demand for robotic solutions in various industries [13][14]